Q3 2023 · 13F-HR
CARNEGIE MELLON UNIVERSITYholdings as filed
Filed 2023-11-01 · accession 0000898432-23-000741
$78.8M
Reported value
7
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 26603R106 | DUOL | DUOLINGO INC | $60.9M | 77.3% | 367,314 | Common | SOLE |
| 46434G103 | IEMG | ISHARES INC | $17.2M | 21.8% | 361,103 | Common | SOLE |
| 142922103 | — | CARMELL THERAPEUTICS CORP | $371,329 | 0.47% | 103,061 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC. | $220,183 | 0.28% | 16,060 | Common | SOLE |
| 64132K102 | — | NEUBASE THERAPEUTICS INC. | $40,855 | 0.05% | 46,970 | Common | SOLE |
| 74039M200 | — | PREDICTIVE ONCOLOGY INC. | $33,146 | 0.04% | 10,358 | Common | SOLE |
| 457919108 | IHT | INNSUITES HOSPITALITY TRUST | $12,700 | 0.02% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.